Diabulimia and insulin-related disordered eating in type 1 diabetes: a phenotype-first perspective

The informal term “diabulimia” was first used in media discourse and later explored in scientific literature in relation to the voluntary restriction or omission of insulin administration as a means of regulating body weight or shape in patients with type 1 diabetes (T1D). However, this term currently lacks formal diagnostic criteria, a recognized nosographic status, a validated etiological model, and clear epidemiologic data. This Perspective, based on a focused, non-systematic appraisal of the literature, examines these diagnostic challenges and proposes a phenotype-first framework for insulin-related disordered eating behavior (IRDEB), defined as intentional insulin manipulation that is functionally related to disordered eating. Meta-analyses document a high burden of eating-disorder symptoms and insulin omission in T1D, whereas reviews of terminology show that “diabulimia” gathers heterogeneous behaviors, motives, and psychopathology under one label, with prevalence estimates that depend on how these are defined and measured. The framework documents insulin behavior, motivation and context, psychopathological phenotype, and medical severity as separate layers, records weight-motivated insulin restriction as a specific descriptor within the IRDEB umbrella, and is complemented by a proposed minimum reporting set for research. Both proposals are conceptual, have not been empirically validated, and do not replace established diagnostic criteria, treatment protocols, or emergency care, which must be guided by acute medical and psychiatric risk. Screening should combine diabetes-specific instruments, clinical interviews, and metabolic data, whereas therapeutic management should involve a multidisciplinary team of diabetologists, psychiatrists, psychologists, and nutritionists. Expert consensus, reliability testing, and prospective evaluation are now needed to establish whether this approach improves clinical documentation and the comparability of research.

Authors

Institutions

Publication Details

Journal
Frontiers in Nutrition
Published
2026-11-19
DOI
https://doi.org/10.3389/fnut.2026.2004129
Primary Topic
Eating Disorders and Behaviors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diabulimia and insulin-related disordered eating in type 1 diabetes: a phenotype-first perspective

Octavian Vasiliu
Frontiers in Nutrition
Eating Disorders and Behaviors
article

Diabulimia and insulin-related disordered eating in type 1 diabetes: a phenotype-first perspective

Octavian Vasiliu
article en

Abstract

The informal term “diabulimia” was first used in media discourse and later explored in scientific literature in relation to the voluntary restriction or omission of insulin administration as a means of regulating body weight or shape in patients with type 1 diabetes (T1D). However, this term currently lacks formal diagnostic criteria, a recognized nosographic status, a validated etiological model, and clear epidemiologic data. This Perspective, based on a focused, non-systematic appraisal of the literature, examines these diagnostic challenges and proposes a phenotype-first framework for insulin-related disordered eating behavior (IRDEB), defined as intentional insulin manipulation that is functionally related to disordered eating. Meta-analyses document a high burden of eating-disorder symptoms and insulin omission in T1D, whereas reviews of terminology show that “diabulimia” gathers heterogeneous behaviors, motives, and psychopathology under one label, with prevalence estimates that depend on how these are defined and measured. The framework documents insulin behavior, motivation and context, psychopathological phenotype, and medical severity as separate layers, records weight-motivated insulin restriction as a specific descriptor within the IRDEB umbrella, and is complemented by a proposed minimum reporting set for research. Both proposals are conceptual, have not been empirically validated, and do not replace established diagnostic criteria, treatment protocols, or emergency care, which must be guided by acute medical and psychiatric risk. Screening should combine diabetes-specific instruments, clinical interviews, and metabolic data, whereas therapeutic management should involve a multidisciplinary team of diabetologists, psychiatrists, psychologists, and nutritionists. Expert consensus, reliability testing, and prospective evaluation are now needed to establish whether this approach improves clinical documentation and the comparability of research.

Frontiers in NutritionVol. 13
Carol Davila University of Medicine and Pharmacy (RO), Spitalul Universitar de Urgenţă Militar Central Dr. Carol Davila (RO)
Eating Disorders and Behaviors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon